TipRanks
Advertisement
Advertisement

BCDA Stock Latest News

BioCardia announces FDA acceptance of Helix pre-submission package
The FlyBioCardia announces FDA acceptance of Helix pre-submission package
2d ago
BCDA
BioCardia Advances Helix Catheter Toward FDA Clearance
PremiumCompany Announcements
BioCardia Advances Helix Catheter Toward FDA Clearance
2d ago
8K
BCDA
BioCardia Advances CardiAMP HF II Heart Failure Trial
PremiumCompany Announcements
BioCardia Advances CardiAMP HF II Heart Failure Trial
14d ago
8K
BCDA
BioCardia Submits Revised FDA De Novo for Helix
PremiumCompany Announcements
BioCardia Submits Revised FDA De Novo for Helix
20d ago
8K
BCDA
BioCardia files revised de novo pre-submission for FDA approval of Helix
PremiumThe Fly
BioCardia files revised de novo pre-submission for FDA approval of Helix
20d ago
BCDA
BioCardia Advances Regulatory Milestones for Cardiovascular Therapies
PremiumCompany AnnouncementsBioCardia Advances Regulatory Milestones for Cardiovascular Therapies
28d ago
8K
BCDA
BioCardia provides update on near term milestones for CardiAMP, Helix
Premium
The Fly
BioCardia provides update on near term milestones for CardiAMP, Helix
28d ago
BCDA
BioCardia Highlights Therapeutic Pipeline at Investor Conference
Premium
Company Announcements
BioCardia Highlights Therapeutic Pipeline at Investor Conference
1M ago
8K
BCDA
BioCardia: Advancing Regulatory Momentum in Helix Catheter and CardiAMP HF Programs Supports Buy Rating and Unchanged $25 Price Target
PremiumRatings
BioCardia: Advancing Regulatory Momentum in Helix Catheter and CardiAMP HF Programs Supports Buy Rating and Unchanged $25 Price Target
2M ago
BCDA
BioCardia gets FDA confirmation of Helix meeting minutes
PremiumThe Fly
BioCardia gets FDA confirmation of Helix meeting minutes
2M ago
BCDA
BioCardia Advances Helix Catheter Toward De Novo Approval
PremiumCompany Announcements
BioCardia Advances Helix Catheter Toward De Novo Approval
2M ago
8K
BCDA
BioCardia Receives Nasdaq Notice on Minimum Bid Price
PremiumCompany Announcements
BioCardia Receives Nasdaq Notice on Minimum Bid Price
2M ago
8K
BCDA
Nasdaq Listing Risks: Potential Delisting Threatens Biocardia’s Market Access and Financial Stability
PremiumCompany AnnouncementsNasdaq Listing Risks: Potential Delisting Threatens Biocardia’s Market Access and Financial Stability
2M ago
BCDA
BioCardia Earnings Call Highlights Regulatory Momentum
Premium
Company Announcements
BioCardia Earnings Call Highlights Regulatory Momentum
2M ago
BCDA
BCDA Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
BCDA Upcoming Earnings Report: What to Expect?
2M ago
BCDA
BioCardia issues letter to shareholders on 2026 priorities
PremiumThe Fly
BioCardia issues letter to shareholders on 2026 priorities
4M ago
BCDA
BioCardia Outlines 2026 CardiAMP Strategy and Milestones
PremiumCompany Announcements
BioCardia Outlines 2026 CardiAMP Strategy and Milestones
4M ago
8K
BCDA
BioCardia Raises $4.4 Million to Extend Cash Runway
PremiumCompany Announcements
BioCardia Raises $4.4 Million to Extend Cash Runway
4M ago
8K
BCDA
BioCardia Gains FDA Path for CardiAMP PMA Approval
PremiumCompany Announcements
BioCardia Gains FDA Path for CardiAMP PMA Approval
5M ago
8K
BCDA
FDA confirms CardiAMP Heart Failure II Trial may support premarket approval
PremiumThe FlyFDA confirms CardiAMP Heart Failure II Trial may support premarket approval
5M ago
BCDA
BioCardia gains PMDA support for CardiAMP heart therapy
Premium
Company Announcements
BioCardia gains PMDA support for CardiAMP heart therapy
5M ago
8K
BCDA
BioCardia Announces Encouraging CardiAMP Chronic Ischemia Data
Premium
Company Announcements
BioCardia Announces Encouraging CardiAMP Chronic Ischemia Data
5M ago
8K
BCDA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >